Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Cromodata

Argentine marketplace turning de-identified records from a 47–84-facility Latin American network into research- and AI-ready clinical datasets.

Open the dossier
Opportunities
5
High confidence
070% and above
Counterparts
5startups and investors
  • Customers 3
  • Co-development 1
  • Investors 1

Customers3

Who could buy, or sell through

Supply Latin American skin images for model training and validation

Legit.Health's CE-marked dermatology AI needs diverse skin types for performance and bias validation. Cromodata's imaging-rich network can supply de-identified, labelled datasets, giving Cromodata a named buyer and Legit.Health data for LatAm expansion.

35%confidence

Evidence from the records

  • “Computer vision and deep learning on skin images, CE-marked as a medical device, with automated severity scores and a clinical data platform.”
  • “claimed network of 47 hospitals and 19M medical images”
If it works
A first data licence and a case study for AI buyers.
First step
Send Legit.Health a dataset spec sheet and sample statistics.

Trial-design and site-feasibility data for BILIX's AKI programme

BILIX is preparing a phase 2b for cardiac-surgery AKI and needs incidence and site data. Cromodata can deliver feasibility counts from its hospital network.

25%confidence

Evidence from the records

  • “BX-001N: phase 1 completed (51 volunteers, Australia), phase 2a under way in Korea (NCT07164833) with KDDF support.”
  • “Marketplace in operation: claimed network of 47 to 84+ healthcare facilities in 5 countries (Argentina, Uruguay, Mexico, Dominican Rep., Brazil); no data buyer publicly named.”
If it works
A pharma-type data contract and possible trial sites in LatAm.
First step
Propose a feasibility query to BILIX.

Provide hemoglobin-linked data to validate anemia AI

Monere's smartphone anemia screening needs validation against lab values in diverse populations. Cromodata's records can provide linked lab data.

20%confidence

Evidence from the records

  • “NiADA app (analysis of a smartphone photo of the lower eyelid) available on Google Play and Apple TestFlight; MIT Solve 2024 selection (30/2,200); no user figures or named pilot.”
  • “Pipeline for de-identifying and standardizing fragmented clinical records (imaging, oncology) into usable datasets, with secure access.”
If it works
A validation dataset and a second AI buyer.
First step
Ask Monere what data it needs for validation.

Co-development1

An integration or joint product

Certify datasets as leak- and poison-free

Buyers of AI training data will require assurance against re-identification and contamination. Hardshell scans datasets for these risks; a 'verified' label increases Cromodata's price and trust.

35%confidence

Evidence from the records

  • “"Data-centric" AI security platform that detects vulnerabilities, poisoning and leaks in training datasets.”
  • “High risk: health data regulation in 5 countries and unproven monetization.”
If it works
Higher buyer conversion through a security certificate.
First step
Run a joint scan on one dataset.

Investors1

A fund whose thesis fits

Pitch Wayra for the seed round via Legit.Health

Wayra invests at seed/Series A across Europe and Latin America, matching Cromodata's seed and expansion to Brazil and Mexico. It backed Legit.Health in the network.

30%confidence

Evidence from the records

  • “Mutua Madrileña (Mutua Ventures), Wayra (Telefónica), Grupo Ribera, business angels”
  • “Seed (announced, not closed)”
If it works
A corporate investor with LatAm reach.
First step
Ask Legit.Health for an introduction to Wayra.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. Critical Medical DeviceswithLove LifesciencesPeers
    Share drug-delivery device lessons with Love Lifesciences

    Both are US pre-seed drug-delivery device companies founded around a clinical pain point. Exchanging contract manufacturer, regulatory consultant and pharma-partnering contacts saves both time and money.

    30%
  2. Roam TechnologieswithByonyksPeers
    Learn from Byonyks' 2025 FDA class II clearance and US launch set-up

    Byonyks obtained FDA 510(k) clearance for a home-therapy device and is setting up US infrastructure, the exact path Roam must follow. A founder exchange can shorten Roam's regulatory and DME launch planning.

    30%
  3. Lampsy HealthwithLegit.HealthPeers
    Learn from Legit.Health's medical-device certification path

    Legit.Health took an AI medical device through CE marking with an ISO 13485 quality system in Iberia; Lampsy faces the same regulatory steps. A founder exchange shortens the learning curve.

    30%
  4. AlgatekwithAtoz Carbon Cycle PlatformPeers
    Regional microalgae alliance for Malaysia

    Atoz builds nature-based carbon solutions with microalgae in Malaysia but has no public traction; Algatek has installed units at Indonesian SOEs. Sharing technology, MRV methods and possibly licensing Algatek units into Malaysia would give both a bigger regional story.

    25%
  5. Learn from a deployed microalgae business next door

    Algatek has leased microalgae units to Indonesian SOEs and claims IoT-monitored capture; Atoz has a prototype. Licensing or co-selling Algatek's MicroForest in Malaysia could give Atoz an immediate product while it builds its platform.

    25%
  6. Love LifescienceswithCritical Medical DevicesPeers
    Share FDA and QMS learnings between two pre-clearance drug-delivery devices

    Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

    25%
  7. ZymoChemwithYeast Bay BioPeers
    Davis fermentation network and scale-up playbook

    ZymoChem's CEO trained at UC Davis, where Yeast Bay Bio was founded in 2025. Sharing contract-fermentation contacts, scale-up lessons and DOE/grant experience is low cost and high value for a seed-stage fermentation company.

    25%
  8. LainTechwithBaniqlPeers
    Battery-metals alliance between two atmospheric leaching processes

    Baniql produces battery-grade nickel MHP from Indonesian laterites at low temperature and pressure; Lain Tech treats sulfides containing cobalt and nickel. Together they can present battery offtakers a complementary low-carbon hydrometallurgy portfolio and share know-how on catalysts and scale-up.

    25%
  9. Amass BiosystemswithRegenratePeers
    Borrow Regenrate’s contract-farming model for intercrops

    Regenrate monetises the intercrop period in France with free seed and guaranteed purchase prices — the same farmer-economics problem Amass must solve. Its contract design is a template for Amass' farmer offer.

    20%
  10. BILIXwithPleryon TherapeuticsPeers
    Exchange on polymer-drug CMC and Asian licensing

    Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

    20%
  11. Pleryon TherapeuticswithBioSapienPeers
    Compare local-delivery regulatory playbooks

    Both companies build localised, extended-release delivery platforms (BioSapien in oncology implants, Pleryon in ophthalmology). Sharing regulatory and CMC learnings on biodegradable delivery systems reduces costly missteps.

    20%
  12. RegenratewithAmass BiosystemsPeers
    Exchange intercrop-for-bioenergy playbooks

    Amass grows a bioenergy crop alongside corn for biomass; Regenrate grows camelina between crops for biofuel. Both sell farmer income diversification to energy buyers and can share off-take and agronomy learnings across EU/US.

    20%
  13. FluvwithTausiPeers
    Share the gig-provider OS playbook

    Tausi runs an AI-powered operating system for independent beauticians with verified providers and a commission model. Fluv faces the same supply-side problem with pet-sitters; exchanging verification, training and retention practices is useful for both.

    15%
  14. PromptendwithNeurath AIPeers
    AI reliability peer exchange

    Both address trust in AI outputs (Promptend for generated code, Neurath for model predictions) and sell to risk-averse engineering buyers; sharing go-to-market learnings on assurance products is useful.

    15%
  15. PsychoTechwithPromptendPeers
    Moldovan finalist cohort coordination

    Both represent Moldova at the SWC final; pooling travel, investor meetings and Startup Moldova support reduces cost, and PsychoTech could pilot Promptend on its client code.

    15%
  16. ShopperoowithPardon AIPeers
    Benchmark against Pardon AI's profitability agents

    Pardon AI sells AI agents that optimise revenue and margins for retail and food service and has been through Techstars. A founder exchange clarifies positioning and possible specialisation (pricing/assortment vs broader profitability).

    15%
  17. VIEROC AIwithWiseUnitPeers
    Exchange voice-agent and chat-agent learnings with WiseUnit

    WiseUnit sells an AI phone receptionist; VIEROC focuses on chat agents. Comparing pricing, churn and model costs, or white-labelling each other's channel, could help both small teams.

    15%
  18. SchoolACEwithKetzaiPeers
    Learn from Ketzai’s path to 40,000 teachers

    Ketzai solved teacher acquisition for AI lesson planning by aligning with official curricula; SchoolACE can learn its playbook and potentially share content tooling for Spanish-speaking US classrooms.

    15%

Similar profiles

Compatibility score with Cromodata

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.